Expertise in
15
conditions

Dr. Dominick Sudano

Rheumatology
7520 N Oracle Rd Ste 100, 
Tucson, AZ 
On Staff At
Accepting New Patients
Expertise in
15
conditions
7520 N Oracle Rd Ste 100, 
Tucson, AZ 

Overview

Dominick Sudano is a Rheumatologist practicing medicine in Tucson, Arizona.

Dr. Sudano is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Axial Spondyloarthritis (AxSpA), Postmenopausal Osteoporosis, and Osteoporosis.

Dr. Sudano is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 8 clinical trials. Dr. Sudano is currently accepting new patients.

Graduate Institution

Drexel University

Residency

University Medical Center Tucson AZ

Specialties

Rheumatology

Licenses

Internal Medicine in AZ

Board Certifications

American Board Of Internal Medicine

Fellowships

Banner - University Medical Center Tucson

Hospital Affiliations

Mt. Graham Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
MercyCare
  • EPO
  • HMO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Catalina Pointe Arthritis Rheumatology Specialists, Md
7520 N Oracle Rd Ste 100, Tucson, AZ 85704

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: March 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: November 19, 2019
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Completed
Publish Date: November 21, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

6 Total Publications

Coccidioides Serologic Screening Practices in Individuals With Rheumatic and Autoimmune Diseases.
Coccidioides Serologic Screening Practices in Individuals With Rheumatic and Autoimmune Diseases.
Journal: ACR open rheumatology
Published: August 31, 2023
Similar Doctors
Expertise in
16
conditions
Dr. Michael Maricic
Rheumatology
Expertise in
16
conditions
Dr. Michael Maricic
Rheumatology

Catalina Pointe Arthritis Rheumatology Specialists, MD

7520 N Oracle Rd Ste 100, 
Tucson, AZ 
 (0.6 miles away)
520-408-1133
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Maricic is a Rheumatologist practicing medicine in Tucson, Arizona. Dr. Maricic is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Osteoporosis, Postmenopausal Osteoporosis, Rheumatoid Arthritis (RA), and Necrotizing Vasculitis. Dr. Maricic is board certified in American Board Of Internal Medicine. Dr. Maricic is currently accepting new patients.

Expertise in
11
conditions
Dr. Ulker Tok
Rheumatology
Expertise in
11
conditions
Dr. Ulker Tok
Rheumatology

Northwest Rheumatology PLLC

403 W Cool Dr Ste 107, 
Tucson, AZ 
 (0.6 miles away)
520-792-2199
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ulker Tok is a Rheumatologist practicing medicine in Tucson, Arizona. Dr. Tok is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Sjogren Syndrome, Postmenopausal Osteoporosis, and Osteoporosis. Dr. Tok is board certified in American Board Of Internal Medicine. Dr. Tok is currently accepting new patients.

Expertise in
8
conditions
Dr. Romy Cabacungan
Rheumatology
Expertise in
8
conditions
Dr. Romy Cabacungan
Rheumatology

Xray Physicians LTD.

2001 W Orange Grove Rd Ste 104, 
Tucson, AZ 
 (0.6 miles away)
480-443-8400
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Romy Cabacungan is a Rheumatologist practicing medicine in Tucson, Arizona. Dr. Cabacungan is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Arthritis, Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, and Rhizomelic Pseudopolyarthritis.

Frequently Asked Questions about Dr. Dominick Sudano

How do I make an appointment with Dr. Dominick Sudano?

You can book an appointment with Dr. Dominick Sudano by calling their office at 520-408-1133. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Dominick Sudano a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Dominick Sudano is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Dominick Sudano specialize in?

While Dr. Dominick Sudano is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Axial Spondyloarthritis (AxSpA), and Postmenopausal Osteoporosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Dominick Sudano participate in research or clinical trials?

Yes. Dr. Dominick Sudano has published 6 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Dominick Sudano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Dominick Sudano accept my insurance?

Dr. Dominick Sudano accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 520-408-1133 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sudano's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 51 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile